目前和新兴的策略,以制抗生素耐药性尿路感染
Aaron Simoni1, Laura Schwartz1,2,3, Guillermo Yepes Junquera4
1The Kidney and Urinary Tract Center, Nationwide Children's Abigail Wexner Research Institute, Columbus, OH, USA.
Nature reviews. Urology
|May 7, 2024
概括
尿路感染中的抗生素耐药性是一个日益严重的问题. 需要新的策略,包括新型化合物和疫苗,以对抗抗性泌尿病原菌并改善患者的治疗结果.
科学领域:
- 微生物学 微生物学
- 传染性疾病 传染性疾病
- 药理学 药理学是指药理学的学科.
背景情况:
- 泌尿病原菌中的抗生素耐药性对患者健康构成重大威胁,导致长时间住院和较差的治疗结果.
- 目前的尿路感染 (UTI) 管理依赖于节约抗生素使用的策略,受到抗菌药物管理和新药开发的影响.
研究的目的:
- 审查目前和未来的预防和控制尿路病原菌抗生素耐药性的策略.
- 为了突出UTI治疗和预防的不断变化的格局.
主要方法:
- 审查过去二十年的临床努力和研究进展.
- 对抗微生物药物管理,国家指导方针和新抗微生物药物开发对尿路感染实践的影响分析.
主要成果:
- 现代的尿道感染实践是由抗菌药物管理,国家政策和新型抗菌药物开发所塑造的.
- 未来的尿路感染管理可能包括微生物群的洞察力,先进的诊断和不断发展的管理计划.
结论:
- 新型方法,如新的杀菌化合物,药物组合,抗粘附药物,重新定位的药物和疫苗对于打击耐药性至关重要.
- 改进的诊断和对微生物群的更好理解将推动未来的尿路感染预防和治疗策略,以改善患者的治疗结果.
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Antibiotic Selection
53.2K
Overview
53.2K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
371
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
371
Drug Elimination by Renal Route: Tubular Secretion
2.3K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.3K
Healthcare Associated Infections II: Preventive Measures
2.6K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.6K
Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K


